Print

AstraZeneca PLC (AZN) Goes into Battle to Defend Crestor  
3/6/2009 8:04:53 AM

LONDON, March 6 (Reuters) - Lawyers at AstraZeneca will begin the long process of defending the company's all-important cholesterol drug Crestor from generic competition in a U.S. courtroom next week.